The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABCELLERA BIOLOGICS INC | COM | 00288U106 | 12,072 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
ALIGOS THERAPEUTICS INC | COM | 01626L105 | 16,771 | 606,548 | SH | SOLE | 606,548 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 272,132 | 3,156,981 | SH | SOLE | 3,156,981 | 0 | 0 | ||
ANNEXON INC | COM | 03589W102 | 3,995 | 159,622 | SH | SOLE | 159,622 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 17,160 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
APPLIED MOLECULAR TRANS INC | COM | 03824M109 | 1,318 | 42,847 | SH | SOLE | 42,847 | 0 | 0 | ||
ATHIRA PHARMA INC | COM | 04746L104 | 32,465 | 947,873 | SH | SOLE | 947,873 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 17,136 | 671,454 | SH | SOLE | 671,454 | 0 | 0 | ||
BCTG ACQUISITION CORP | COM | 05492W103 | 2,288 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BIOHAVEN PHARMACTL HLDG CO L | COM | G11196105 | 17,142 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | |
BIOXCEL THERAPEUTICS INC | COM | 09075P105 | 19,866 | 430,000 | SH | SOLE | 430,000 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 3,957 | 123,465 | SH | SOLE | 123,465 | 0 | 0 | ||
BRISTOL-MYERS SQUIBB CO | RIGHT 99/99/9999 | 110122157 | 3,485 | 5,050,000 | SH | SOLE | 5,050,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 15,834 | 477,928 | SH | SOLE | 477,928 | 0 | 0 | ||
CALLIDITAS THERAPEUTICS AB | SPONSERED ADS | 13124Q106 | 10,086 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | *W EXP 06/09/202 | 15678U102 | 188 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 1,658 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | 21,567 | 1,920,500 | SH | SOLE | 1,920,500 | 0 | 0 | ||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 14,292 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
CURIS INC | COM NEW | 231269200 | 9,828 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 33,692 | 1,604,392 | SH | SOLE | 1,604,392 | 0 | 0 | ||
EARGO INC | COM | 270087109 | 2,241 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ESSA PHARMA INC | COM NEW | 29668H708 | 6,562 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 4,606 | 699,999 | SH | SOLE | 699,999 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 48,860 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | ||
FS DEV CORP | COM CL A | 303020101 | 1,100 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
GENERATION BIO CO | COM | 37148K100 | 482 | 17,000 | SH | SOLE | 17,000 | 0 | 0 | ||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 3,615 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 | ORD SHS | G4411D109 | 3,843 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 2,274 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 13,244 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 3,382 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
KALVISTA PHARMACEUTICALS INC | COM | 483497103 | 9,305 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 12,191 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 31,743 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 22,659 | 569,602 | SH | SOLE | 569,602 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 6,877 | 110,920 | SH | SOLE | 110,920 | 0 | 0 | ||
LARIMAR THERAPEUTICS INC | COM | 517125100 | 15,308 | 715,000 | SH | SOLE | 715,000 | 0 | 0 | ||
MIRAGEN THERAPEUTICS INC | COM NEW | 60463E202 | 9,048 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 10,982 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 103,406 | 1,682,178 | SH | SOLE | 1,682,178 | 0 | 0 | ||
NOVUS THERAPEUTICS INC | COM | 67011N204 | 3,451 | 224,071 | SH | SOLE | 224,071 | 0 | 0 | ||
NURIX THERAPEUTICS INC | COM | 67080M103 | 7,572 | 230,297 | SH | SOLE | 230,297 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 180,006 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
OPTHEA LTD | SPONSORED ADS | 68386J208 | 1,794 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 2,842 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PANACEA ACQUISITION CORP | UNIT 99/99/9999 | 698102209 | 2,552 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
PASSAGE BIO INC | COM | 702712100 | 8,807 | 344,438 | SH | SOLE | 344,438 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 1,736 | 76,426 | SH | SOLE | 76,426 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 6,151 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 5,177 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 23,217 | 676,894 | SH | SOLE | 676,894 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 6,371 | 121,562 | SH | SOLE | 121,562 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 13,902 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
TG THERAPEUTICS INC | COM | 88322Q108 | 44,217 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
THERAPEUTICS ACQUISITION COR | COM CL A | 88339T103 | 6,960 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 1,667 | 61,152 | SH | SOLE | 61,152 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 3,720 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
VINCERA PHARMA INC | UNIT 12/24/2025 | 92731L205 | 7,704 | 400,000 | SH | SOLE | 400,000 | 0 | 0 |